This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lam, J. Y. Articles by Fuster, V. Search for Related Content PubMed PubMed Citation Articles by Lam, J. Y. Articles by Fuster, V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITROGLYCERIN

Circulation, Vol 78, 712-716, Copyright © 1988 by American Heart Association

ARTICLES

Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug

JY Lam, JH Chesebro and V Fuster
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

Endothelial injury in vivo is associated with platelet deposition and a localized platelet-dependent vasoconstrictive response. To assess the influence of nitroglycerin on platelets and vasoconstriction, quantitative 111In-labeled platelet deposition (no platelets x 10(6)/cm2) of the injured segment and the degree of angiographic vasoconstriction (percent diameter narrowing proximal and distal to the dilated segment) produced during injury by balloon angioplasty of the common carotid arteries were studied in heparinized normal pigs that were sacrificed immediately after the procedure. In deeply injured (injury extending through the internal elastic lamina) compared with mildly injured (deendothelialization only) arteries, there was both greater platelet deposition (63.8 vs. 6.9, p = 0.04) and more vasoconstriction (30% vs. 19%, p = 0.02). In the presence of deep arterial wall injury, nitroglycerin given intravenously at a dose sufficient to lower mean arterial pressure by 9 +/- 2% significantly decreased both platelet deposition (16.2 vs. 63.8, p less than 0.008) and the vasoconstrictive response (20 vs. 30%, p less than 0.02) relative to control. However, in the presence of mild arterial wall injury, nitroglycerin decreased vasoconstriction relative to control (10% vs. 19%, p less than 0.01) without causing a significant decrease in the already low level of platelet deposition (5.6 vs. 6.9, respectively; p = NS), suggesting a direct smooth muscle relaxant effect of nitroglycerin. This is the first reported in vivo effectiveness of nitroglycerin in the reduction of platelet deposition after deep arterial injury.

This article has been cited by other articles:

				G. Vilahur, E. Segales, E. Salas, and L. Badimon Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model Circulation, September 21, 2004; 110(12): 1686 - 1693. [Abstract] [Full Text] [PDF]

				M. R Miller, I. S Hanspal, P. W.F Hadoke, D. E Newby, A. G Rossi, D. J Webb, and I. L Megson A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury Cardiovasc Res, March 1, 2003; 57(3): 853 - 860. [Abstract] [Full Text] [PDF]

				D. A. Zvara Treatment of Perioperative Myocardial Ischemia Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2001; 5(2): 166 - 183. [Abstract] [PDF]

				D. Hebert and J. Y. T. Lam Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2311 - 2316. [Abstract] [Full Text] [PDF]

				N. Maalej, R. Albrecht, J. Loscalzo, and J. D. Folts The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1408 - 1414. [Abstract] [Full Text] [PDF]

				J. Molloy, J. F. Martin, P. A. Baskerville, S. C. A. Fraser, and H. S. Markus S-Nitrosoglutathione Reduces the Rate of Embolization in Humans Circulation, October 6, 1998; 98(14): 1372 - 1375. [Abstract] [Full Text] [PDF]

				J. G. Diodati, N. Dakak, D. M. Gilligan, and A. A. Quyyumi Effect of Atherosclerosis on Endothelium-Dependent Inhibition of Platelet Activation in Humans Circulation, July 7, 1998; 98(1): 17 - 24. [Abstract] [Full Text] [PDF]

				S. Dikalov, B. Fink, M. Skatchkov, O. Sommer, and E. Bassenge Formation of Reactive Oxygen Species in Various Vascular Cells During Glyceryltrinitrate Metabolism Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 51 - 61. [Abstract] [PDF]

				P. Provost, J. Tremblay, and Y. Merhi The Antiadhesive and Antithrombotic Effects of the Nitric Oxide Donor SIN-1 Are Combined With a Decreased Vasoconstriction in a Porcine Model of Balloon Angioplasty Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1806 - 1812. [Abstract] [Full Text]

				D. Hebert, J.-X. Xiang, and J. Y.T. Lam Persistent Inhibition of Platelets During Continuous Nitroglycerin Therapy Despite Hemodynamic Tolerance Circulation, March 4, 1997; 95(5): 1308 - 1313. [Abstract] [Full Text]

				J. S. Mruk, P. Zoldhelyi, M. W.I. Webster, M. Heras, D. E. Grill, D. R. Holmes Jr, V. Fuster, and J. H. Chesebro Does Antithrombotic Therapy Influence Residual Thrombus After Thrombolysis of Platelet-Rich Thrombus? : Effects of Recombinant Hirudin, Heparin, or Aspirin Circulation, February 15, 1995; 93(4): 792 - 799. [Abstract] [Full Text]

				P. Golino, F. Piscione, C. R. Benedict, H. V. Anderson, M. Cappelli-Bigazzi, C. Indolfi, M. Condorelli, M. Chiariello, and J. T. Willerson Local Effect of Serotonin Released during Coronary Angioplasty N. Engl. J. Med., February 24, 1994; 330(8): 523 - 528. [Abstract] [Full Text]

				Z. Kaposzta, J. F. Martin, and H. S. Markus Switching off Embolization From Symptomatic Carotid Plaque Using S-Nitrosoglutathione Circulation, March 26, 2002; 105(12): 1480 - 1484. [Abstract] [Full Text] [PDF]